SpIntellx
Pittsburgh
About SpIntellx
SpIntellx has the first-mover advantage in Precision Pathology and Spatially Intelligent Biology by applying truly unbiased spatial analytics software powered by explainable AI to decipher the complex cancer biology. SpIntellx’s software solutions have the potential to unlock a plethora of new applications in medicine and research by answering the fundamental question “Why?”, thus revealing the underlying patient-specific disease network biology, across each stage of the drug development, diagnostics, and treatment pipelines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.7M
- Funding stage: Seed
- Last round: Convertible Note (Feb 2023)
- Website: spintellx.com
- Phone: +1 412-2123115
Industries & Categories
Artificial Intelligence (AI), Biopharma, Biotechnology, Life Science, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/spintellx-114454 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.